The project aims at dissecting the role of neutrophils in the pathogenesis of T1DM.

The lab studies the metabolic, molecular and cellular requirements for mounting and controlling B cell response at the mucosal interfaces.

The project a project aims at: 1. the clarification of the PZ mechanism of action as a tool to identify potential new targets; 2. the screening of FDA approved orphan drugs to hit the TZ identified molecular targets. The candidate will acquire experience in cell and molecular biology, advanced imaging approaches and high throughput screening technologies.

Anna Kajaste's group is interested in studying the molecular mechanisms of host-vector interplay in the context of hematopoietic stem cell gene therapy of monogenic inflammatory diseases, with particular focus on innate immunity and host responses to transduction.

Post-Doctoral position (Assegno di Ricerca) at the Department of Molecular Biotechnology and Health Sciences of the University of Torino, Molecular Biotechnology Center, Via Nizza 52.